The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.25
Bid: 20.50
Ask: 22.00
Change: 0.15 (0.71%)
Spread: 1.50 (7.317%)
Open: 21.50
High: 22.00
Low: 21.25
Prev. Close: 21.10
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Market update

27 Mar 2014 07:00

RNS Number : 2955D
Iofina PLC
27 March 2014
 

 

 

27 March 2014

 

Iofina plc

("Iofina" or the "Group")

(LSE AIM: IOF)

 

Completion of IO#5 Iodine Extraction Plant

IO#6 on Track for Completion in Q2

Mobile Units Planned

Water Project Update

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce that the construction of the Group's IO#5 iodine extraction plant, based on Iofina's WET® IOSorb™ technology, is now complete and under the control of Iofina's operation team. IO#5 is located in the vicinity of the Group's IO#2, IO#3 and IO#4 iodine extraction plants.

 

Following operator approval, the Board reports that IO#5's tie-in to the well operator is also complete, with production staff in the process of both hydro-testing, prior to the acceptance of brine water, and in-line automation systems testing.

 

Production of iodine for both IO#4 and IO#5 is conditional upon final regulatory inspection and approval. The inspection occurred on 14 March 2014, with approval expected shortly. Construction of IO#6 continues, with completion expected to occur in Q2 2014. Images relating to IO#6's progress can be viewed at www.iofina.com.

 

Following the commissioning of IO#6, Iofina will have built four similar purpose facilities in addition to IO#1 and IO#2. The Board is of the view that, prior to work commencing on further full scale plants, an operational review be undertaken. This review, scheduled for completion in the autumn, will include considerations for improvements to construction methodology, reduction in total cost, improvement in time to complete, and optimal plant sizing. Construction of further full size plants will be delayed until this review is complete which will reduce short term capital expenditures and improve cash flows. Operational teams continue to focus on maximizing the performance of all existing plants. The Board believes there is overwhelming evidence that the Group's WET® IOSorb™ technology patented process has proven itself to a high level.

 

Subject to completing minor design modifications, the first two mobile units or mini WET® IOSorb™ technology plants (namely 'IOA' and 'IOB') are planned to be ordered throughout 2014 on a turnkey basis for operational deployment in the fourth quarter. The Group has some very high parts per million (ppm) but low brine volume sites where the units can be economically deployed. The Group is highly encouraged by the potential returns of the mobile units and envisages further mobile unit installations in 2015.

 

The Group will give an update on its first quarter when it releases its results for the year ended 31st December 2013, scheduled for the week commencing 21st April.

 

On our non-core water project, the Group submitted the requested information to the Montana Department of Natural Resources and Conservation. The Group views our response as satisfying the raised objections and awaits comment from the regulatory board.

 

Commenting on today's update, Iofina's CEO George Lantz commented:

 

"The completion of IO#5 solidifies Iofina's capabilities of constructing and operating multiple plants simultaneously. With the completion of IO#4 and IO#5, the addition of IO#6 and implementation of our mobile strategy, Iofina continues to advance as a major player in the iodine market."

 

For further information, please contact:

 

George Lantz, CEO

Iofina plc

Tel: +44 (0) 20 3006 3135

www.iofina.com 

 

John Prior/Rupert Krefting/Huw Jeremy

Numis

Tel: +44(0)20 7260 1000

 

Rob Collins

GMP Securities

Tel: +44(0)20 7647 2800

 

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEMFUMFLSESD
Date   Source Headline
29th Aug 20194:41 pmRNSSecond Price Monitoring Extn
29th Aug 20194:35 pmRNSPrice Monitoring Extension
13th Aug 20197:00 amRNSIncorporation of IofinaEX Global
29th Jul 20197:00 amRNSGrant of Share Options
24th Jul 20193:08 pmRNSHolding(s) in Company
16th Jul 20192:17 pmRNSHolding(s) in Company
12th Jul 20197:00 amRNSH1 2019 Update
17th Jun 20191:49 pmRNSHolding(s) in Company
17th Jun 201910:55 amRNSHolding(s) in Company
17th Jun 201910:53 amRNSHolding(s) in Company
13th Jun 201912:00 pmRNSResult of AGM and Open Offer
13th Jun 20197:00 amRNSIofinaEX Application Conditionally Approved
20th May 20197:00 amRNSProposed Placing and Open Offer
14th May 20197:00 amRNSStatement regarding share price rise
1st May 20197:00 amRNSFinal Results
17th Apr 20197:00 amRNSQ1 2019 Market Update
1st Apr 20197:00 amRNSCompletion of Debt Restructuring
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSDebt Restructuring
1st Feb 20194:40 pmRNSSecond Price Monitoring Extn
1st Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Jan 20197:00 amRNSChange of Registered Office
17th Jan 20197:00 amRNSMarket Update
20th Nov 20184:40 pmRNSSecond Price Monitoring Extn
20th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20187:00 amRNSDirector Appointment
18th Oct 20184:40 pmRNSSecond Price Monitoring Extn
18th Oct 20184:35 pmRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSQ3 2018 Update
20th Sep 20187:00 amRNSInterim Results
16th Jul 20187:00 amRNSH1 2018 Update
18th Jun 20187:00 amRNSMarket update
14th Jun 20187:00 amRNSGrant of Options
13th Jun 201811:30 amRNSResult of AGM
30th Apr 20187:00 amRNSFinal Results and Notice of AGM
18th Apr 20187:00 amRNSQ1 2018 Market Update
16th Apr 20181:30 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
20th Mar 20183:05 pmRNSHolding(s) in Company
15th Mar 20181:24 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSProduction commences at IO#7
30th Jan 20183:00 pmRNSHolding(s) in Company
15th Jan 20187:00 amRNSMarket Update
14th Dec 20177:00 amRNSMarket Update
16th Nov 20177:00 amRNSIO#7 Progress and Market Update
20th Oct 20174:40 pmRNSSecond Price Monitoring Extn
20th Oct 20174:35 pmRNSPrice Monitoring Extension
10th Oct 20177:00 amRNSQ3 2017 Market Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.